Provided by Tiger Trade Technology Pte. Ltd.

LivaNova PLC

78.26
-0.4800-0.61%
Pre-market: 79.160.9007+1.15%04:14 EDT
Volume:823.21K
Turnover:64.62M
Market Cap:4.30B
PE:23.09
High:80.00
Open:78.65
Low:78.00
Close:78.74
52wk High:85.76
52wk Low:48.82
Shares:54.93M
Float Shares:54.68M
Volume Ratio:1.70
T/O Rate:1.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.39
EPS(LYR):-4.4500
ROE:15.40%
ROA:5.23%
PB:3.24
PE(LYR):-17.59

Loading ...

Press Release: LivaNova Reports First-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance

Dow Jones
·
May 06

Earning Preview: LivaNova PLC Q1 revenue is expected to increase by 14.48%, and institutional views are predominantly bullish

Earnings Agent
·
Apr 30

Annals publishes 12-month OSPREY trial data for LivaNova sleep apnea device

Reuters
·
Apr 21

Annals of Internal Medicine Publishes 12-Month Results From LivaNova’s Osprey Clinical Study for Obstructive Sleep Apnea

THOMSON REUTERS
·
Apr 21

Press Release: LivaNova to Announce First-Quarter 2026 Results

Dow Jones
·
Mar 25

LivaNova schedules a conference call on first-quarter FY2026 results; access code set at 946097

Reuters
·
Mar 25

A Look At LivaNova (LIVN) Valuation After Recent Share Price Weakness

Simply Wall St.
·
Mar 25

LivaNova wins FDA PMA approval for aura6000 obstructive sleep apnea system

Reuters
·
Mar 19

LivaNova Plc - Next-Gen Mri-Compatible Device Expected to Launch in First Half of 2027 Pending FDA Review

THOMSON REUTERS
·
Mar 19

LivaNova Receives U.S. Food and Drug Administration Premarket Approval for Aura6000 System to Treat Moderate to Severe Obstructive Sleep Apnea

THOMSON REUTERS
·
Mar 19

LivaNova PLC Signals Cautious Growth After Strong Quarter

TIPRANKS
·
Mar 01

LivaNova Is Maintained at Equal-Weight by Barclays

Dow Jones
·
Feb 27

LivaNova price target raised to $73 from $66 at Goldman Sachs

TIPRANKS
·
Feb 26

LivaNova Is Maintained at Buy by Needham

Dow Jones
·
Feb 26

Needham Adjusts Price Target on LivaNova to $81 From $64

MT Newswires Live
·
Feb 26

Stock Track | LivaNova Plummets 6.86% Intraday Despite Q4 Beat as 2026 Guidance Disappoints and GAAP Loss Weighs

Stock Track
·
Feb 25

LivaNova PLC reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Feb 25

LivaNova Q4 revenue, EPS tops expectations on cardiopulmonary market demand

Reuters
·
Feb 25

LivaNova sees FY26 adjusted EPS $4.15-$4.25, consensus $4.13

TIPRANKS
·
Feb 25

Earnings Flash (LIVN) LivaNova Posts Q4 Revenue $360.9M, vs. FactSet Est of $353.3M

MT Newswires Live
·
Feb 25